Shortlisted ideas are being evaluated against the eligibility criteria by a selection panel that includes Sanofi Genzyme and Regeneron, our Challenge steering committee as well as the OpenIDEO Challenge team. This will be followed by a period of due diligence and grant review process before signing an agreement.

Meet our steering committee members who are helping to ensure selected grant recipients demonstrate their proposals’ potential impact for addressing the emotional and social burden due to bullying for the atopic dermatitis (AD) community.

SAGLB.AD.19.08.1277(1)a ǀ November 2019